{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.666.5.1953","meta":{"versionId":"3","lastUpdated":"2013-03-30T22:03:25.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"Lantana Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2013-03-30"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.1953","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.666.5.1953"}],"version":"20130401","name":"HospitalMeasuresPONeomycinSulfate","title":"Hospital measures-PO Neomycin sulfate","status":"active","experimental":false,"date":"2013-03-30T22:03:25-04:00","publisher":"Lantana","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: ),(Data Element Scope: ),(Inclusion Criteria: ),(Exclusion Criteria: )","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","concept":[{"code":"311932","display":"Neomycin 25 MG/ML Oral Solution"},{"code":"756319","display":"Neomycin 20 MG/ML Oral Solution"},{"code":"866042","display":"Neomycin Sulfate 500 MG Oral Tablet"}]}]},"expansion":{"identifier":"urn:uuid:37971c28-1272-4c8c-a617-f6bfd2fc93b2","timestamp":"2023-12-11T03:08:17-05:00","total":1,"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"866042","display":"neomycin sulfate 500 MG Oral Tablet"}]}}